{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:29:05Z","timestamp":1791307745387,"version":"4.3.1"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T00:00:00Z","timestamp":1524614400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2018.00197","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T04:14:17Z","timestamp":1524629657000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Neural and Endocrinal Pathobiochemistry of Vitiligo: Comparative Study for a Hypothesized Mechanism"],"prefix":"10.3389","volume":"9","author":[{"given":"Mohamed-I.","family":"Kotb El-Sayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Abd El-Ghany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Refaat R.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","article-title":"A review of the worldwide prevalence of vitiligo in children\/adolescents and adults","volume":"51","author":"Kruger","year":"2012","journal-title":"Int J Dermatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1046\/j.0022-202x.2001.01459.x","article-title":"Mitochondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo","volume":"117","author":"Dell\u2019Anna","year":"2001","journal-title":"J Invest Dermatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399401003362","article-title":"Immunological pathomechanisms in vitiligo","volume":"23","author":"Kemp","year":"2001","journal-title":"Expert Rev Mol Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/labinvest.3780318","article-title":"Autoimmune melanocyte destruction in vitiligo","volume":"81","author":"van den Wijngaard","year":"2001","journal-title":"Lab Invest"},{"key":"B5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1523-1747.2001.00220.x","article-title":"Epidermal H2O2 accumulation alters tetrahydrobiopterin (6bh4) recycling in vitiligo: identification of a general mechanism in regulation of all 6BH4-dependent processes?","volume":"116","author":"Schallreuter","year":"2001","journal-title":"J Invest Dermatol"},{"key":"B6","first-page":"255","article-title":"Vitiligo disease triggers: psychological stressors preceding the onset of disease","volume":"95","author":"Silverberg","year":"2015","journal-title":"Cutis"},{"key":"B7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/9780470760116.ch18","article-title":"Neural pathogenesis","volume-title":"Vitiligo","author":"Orecchia","year":"2000"},{"key":"B8","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1590\/abd1806-4841.20142717","article-title":"Vitiligo \u2013 part 2 \u2013 classification, histopathology and treatment","volume":"89","author":"Reichert-Faria","year":"2014","journal-title":"An Bras Dermatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"42394","DOI":"10.1038\/srep42394","article-title":"Dysregulated autophagy increased melanocyte sensitivity to H2O2-induced oxidative stress in vitiligo","volume":"7","author":"He","year":"2017","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4161\/derm.3.1.14617","article-title":"Neuroendocrinology of the skin: an overview and selective analysis","volume":"3","author":"Zmijewski","year":"2011","journal-title":"Dermatoendocrinol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4172\/2472-1077.1000105","article-title":"The potential role of melatonin on mental disorders: insights from physiology and pharmacology","volume":"2","author":"Sun","year":"2016","journal-title":"Bipolar Disord"},{"key":"B12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4172\/2376-0427.1000155","article-title":"Assessment of prolactin levels in vitiligo patients and healthy controls and it\u2019s association with severity of disease","volume":"2","author":"Radvar","year":"2014","journal-title":"Pigm Disord"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/sj.jid.5700257","article-title":"Estrogens can contribute to hydrogen peroxide generation and quinone-mediated DNA damage in peripheral blood lymphocytes from patients with vitiligo","volume":"126","author":"Schallreuter","year":"2006","journal-title":"J Invest Dermatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1038\/jid.2015.56","article-title":"Skin under the (Spot)-light: crosstalk with the central hypothalamic\u2013pituitary\u2013adrenal (HPA) axis","volume":"135","author":"Jozic","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4161\/derm.3.3.17027","article-title":"Thyroid hormone action on skin","volume":"3","author":"Safer","year":"2011","journal-title":"Dermatoendocrinol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1590\/S0365-05962013000100009","article-title":"Mechanisms regulating melanogenesis","volume":"88","author":"Videria","year":"2013","journal-title":"An Bras Dermatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4061\/2011\/938257","article-title":"Association between vitiligo and thyroid autoimmunity","volume":"2011","author":"Kasumagic-Halilovic","year":"2011","journal-title":"J Thyroid Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/978-1-61779-328-8_27","article-title":"Determination of neurotransmitter levels in models of Parkinson\u2019s disease by HPLC-ECD","volume":"793","author":"Yang","year":"2011","journal-title":"Methods Mol Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.12998\/wjcc.v3.i3.221","article-title":"Highlights in pathogenesis of vitiligo","volume":"3","author":"Mohammed","year":"2015","journal-title":"World J Clin Cases"},{"key":"B20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/jidsymp.1997.9","article-title":"Epidermal adrenergic signal transduction as part of the neuronal network in the human epidermis","volume":"2","author":"Schallreuter","year":"1997","journal-title":"Dermatol Symp Proc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1755-148X.2011.00898.x","article-title":"L-tyrosine and L-DOPA as hormone-like regulators of melanocytes functions","volume":"25","author":"Slominski","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1034\/j.1600-0749.2003.00015.x","article-title":"Catecholamines increases in the urine of non-segmental vitiligo especially during its active phase","volume":"16","author":"Cucchi","year":"2003","journal-title":"Pigment Cell Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.bbrc.2004.01.082","article-title":"Activation\/deactivation of acetylcholinesterase by H2O2: more evidence for oxidative stress in vitiligo","volume":"315","author":"Schallreuter","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"B24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/exd.12103","article-title":"Vitiligo: interplay between oxidative stress and immune system","volume":"22","author":"Laddha","year":"2013","journal-title":"Exp Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/jid.2014.65","article-title":"Melanocytes as instigators and victims of oxidative stress","volume":"134","author":"Denat","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jdermsci.2007.03.009","article-title":"Glutathione prevented dopamine-induced apoptosis of melanocytes and its signaling","volume":"47","author":"Park","year":"2007","journal-title":"J Dermatol Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1159\/000246877","article-title":"Normal range plasma catecholamines in patients with generalized and acrofacial vitiligo: preliminary report","volume":"189","author":"Orecchia","year":"1994","journal-title":"Dermatology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1096\/fj.04-2079rev","article-title":"The cutaneous serotoninergic\/melatoninergic system: securing a place under the sun","volume":"19","author":"Slominski","year":"2005","journal-title":"FASEB J"},{"key":"B29","first-page":"810","article-title":"Disorders of melanocytes","volume-title":"Dermatology in General Medicine","author":"Mosher","year":"1987"},{"key":"B30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1677\/joe.0.0900089","article-title":"Interaction of a-melanocyte stimulating hormone, melatonin, cyclic AMP and cyclic GMP in the control of melanogenesis in hair follicle melanocytes in vitro","volume":"90","author":"Weatherhead","year":"1981","journal-title":"J Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0738-081X(03)00048-8","article-title":"Vitiligo and leukoderma in children","volume":"21","author":"Herane","year":"2003","journal-title":"Clin Dermatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1600-0749.1996.tb00098.x","article-title":"Vitiligo, psoralen, and melanogenesis \u2013 some observations and understanding","volume":"9","author":"Chakraborty","year":"1996","journal-title":"Pigment Cell Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1152\/physrev.00044.2003","article-title":"Melanin pigmentation in mammalian skin and its hormonal regulation","volume":"84","author":"Slominski","year":"2004","journal-title":"Physiol Rev"},{"key":"B34","first-page":"683","article-title":"[Tryptophan metabolism in vitiligo]","volume":"22","author":"Kurbanov","year":"1976","journal-title":"Vopr Med Khim"},{"key":"B35","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/0738-081X(89)90063-1","article-title":"Serum antibodies in vitiligo patients","volume":"7","author":"Bystryn","year":"1989","journal-title":"Clin Dermatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","article-title":"Evidence for an autoimmune pathogenesis of vitiligo","volume":"16","author":"Ongenea","year":"2003","journal-title":"Pigment Cell Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jaad.2010.10.043","article-title":"Vitiligo: a comprehensive overview part II: treatment options and approach to treatment","volume":"65","author":"Felsten","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00403-012-1208-6","article-title":"Exploring the role of prolactin in psoriasis","volume":"304","author":"Langan","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"B39","first-page":"959","article-title":"Andrews\u2019 diseases of the skin","volume-title":"Clinical Dermatology","author":"James","year":"2011"},{"key":"B40","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1006\/bbrc.2002.6727","article-title":"Oxidative stress in vitiligo: photo-oxidation of pterins produces H2O2 and pterin-6-carboxylic acid","volume":"292","author":"Rokos","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"B41","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.mrrev.2003.06.016","article-title":"Oestrogenic compounds and oxidative stress (in human sperm and lymphocytes in the comet assay)","volume":"544","author":"Anderson","year":"2003","journal-title":"Mutat Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jaad.2011.06.001","article-title":"Melasma: a comprehensive update: part II","volume":"65","author":"Sheth","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e15104","DOI":"10.7554\/eLife.15104","article-title":"Sex steroids regulate skin pigmentation through nonclassical membrane-bound receptors","volume":"5","author":"Natale","year":"2016","journal-title":"Elife"},{"key":"B44","doi-asserted-by":"publisher","first-page":"373","DOI":"10.5021\/ad.2010.22.4.373","article-title":"What should be considered in treatment of melasma","volume":"22","author":"Kang","year":"2010","journal-title":"Ann Dermatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4103\/0110-5558.72420","article-title":"Male hypogonadism: symptoms and treatment","volume":"1","author":"Kumar","year":"2010","journal-title":"J Adv Pharm Technol Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4103\/0019-5154.103067","article-title":"Childhood vitiligo: treatment paradigms","volume":"57","author":"Kanwar","year":"2012","journal-title":"Indian J Dermatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/00926230600998482","article-title":"The problems in sexual functions of vitiligo and chronic urticaria patients","volume":"33","author":"Sukan","year":"2007","journal-title":"J Sex Marital Ther"},{"key":"B48","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.autrev.2011.02.004","article-title":"Immunopathogenesis of vitiligo","volume":"10","author":"Sandoval-Cruz","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1155\/2015\/631927","article-title":"Oxidative stress and immune system in vitiligo and thyroid diseases","volume":"2015","author":"Colucci","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"B50","doi-asserted-by":"publisher","first-page":"140","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20170803","article-title":"Prevalence of thyroid dysfunction and anti-thyroid peroxidase antibodies in vitiligo patients","volume":"3","author":"Jishna","year":"2017","journal-title":"Int J Res Dermatol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1055\/s-0029-1225629","article-title":"Effect of testosterone on thyroid weight and function in iodine deficient castrated rats","volume":"41","author":"Bahrami","year":"2009","journal-title":"Horm Metab Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"34","DOI":"10.9790\/0853-141093437","article-title":"A study on association between vitiligo and thyroid dysfunction","volume":"14","author":"Biswas","year":"2015","journal-title":"J Dental Med Sci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1687-9856-2011-18","article-title":"Incidence of vitiligo in children with Graves\u2019 disease and Hashimoto\u2019s thyroiditis","volume":"2011","author":"Prindaville","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1096\/fj.06-7398com","article-title":"Proopiomelanocortin (POMC), the ACTH\/melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis","volume":"21","author":"Rousseau","year":"2007","journal-title":"FASEB J"},{"key":"B55","doi-asserted-by":"publisher","first-page":"14579","DOI":"10.1038\/srep14579","article-title":"Melanin production through novel processing of proopiomelanocortin in the extracellular compartment of the auricular skin of C57BL\/6 mice after UV-irradiation","volume":"5","author":"Yamamoto","year":"2015","journal-title":"Sci Rep"},{"key":"B56","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.abb.2014.07.003","article-title":"Cyclic AMP (camp) signaling in melanocytes and melanoma","volume":"563","author":"Rodr\u00edguez","year":"2014","journal-title":"Arch Biochem Biophys"},{"key":"B57","doi-asserted-by":"publisher","first-page":"E701","DOI":"10.1152\/ajpendo.00519.2004","article-title":"CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH","volume":"288","author":"Slominski","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B58","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1677\/joe.0.181R001","article-title":"Corticotropin releasing hormone stimulates NF-kappa B in human epidermal keratinocytes","volume":"181","author":"Zbytek","year":"2004","journal-title":"J Endocrinol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1016\/j.peptides.2006.07.017","article-title":"CRH inhibits NF-kB signaling in human melanocytes","volume":"27","author":"Zbytek","year":"2006","journal-title":"Peptides"},{"key":"B60","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1600-0749.1992.tb00003.x","article-title":"Catecholamines and vitiligo","volume":"5","author":"Morrone","year":"1992","journal-title":"Pigment Cell Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2008.05.006","article-title":"Neuroendocrine interactions in the immune system","volume":"252","author":"Taub","year":"2008","journal-title":"Cell Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0192-0561(93)90029-X","article-title":"In vivo activation of macrophages by prolactin from young and aging mice","volume":"15","author":"Chen","year":"1993","journal-title":"Int J Immunopharmacol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2018.00197\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T04:14:24Z","timestamp":1524629664000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2018.00197\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,25]]},"references-count":62,"alternative-id":["10.3389\/fendo.2018.00197"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2018.00197","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,25]]},"article-number":"197"}}